Latest Parkin Stories
Researchers at the University of Montreal and the Institut universitaire de gératrie de Montréal examined brain changes over 20 months in Parkinson's patients with and without mild cognitive impairment (MCI) at the early stages of the disease.
A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and glucosylceramides are metabolized.
Researchers at Johns Hopkins and elsewhere have brought new clarity to the picture of what goes awry in the brain during Parkinson's disease and identified a compound that eases the disease's symptoms in mice.
Researchers have discovered how genetic mutations linked to Parkinson's disease might play a key role in the death of brain cells, potentially paving the way for the development of more effective drug treatments.
A study by Valentina Moskvina, Ph.D., of the Cardiff University School of Medicine, Wales, United Kingdom, and colleagues, examined the genetic overlap between Parkinson disease (PD) and Alzheimer disease (AD).
Everything About Parkinson’s Disease created by Lianna Marie is a new book that covers an effective Parkinson’s disease treatment, safe methods, step-by-step techniques, diet plans, natural
Researchers at Tel Aviv University (TAU) say an artificial sweetener could be a potential treatment for Parkinson's disease.
Cells have a sophisticated system to control and dispose of defective, superfluous proteins and thus to prevent damage to the body.
McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson’s disease.